Commentary

D1.454 Qualifying expenditure on contracted out R&D

Corporate tax
Corporate tax | Commentary

D1.454 Qualifying expenditure on contracted out R&D

Corporate tax | Commentary

D1.454 Qualifying expenditure on contracted out R&D

The provisions in this article apply to large companies (for expenditure incurred before 1 April 2017) and SMEs (for expenditure incurred before 1 April 2012).

A company may claim vaccine research relief in respect of qualifying R&D which it subcontracts to another person1. The treatment depends upon whether the parties are connected and is the same as that applying to R&D expenditure2. For details see D1.414.

To continue reading
View the latest version of this document, as well as thousands of others like it, sign in to TolleyLibrary or register for a free trial